Table 4.
Receiver operating characteristic (ROC) analysis to determine diagnostic accuracy in the differentiation of patients with endometriosis.
| Factor | Parameter [%] | Prognostic Value | Youden Index | Area under the Curve (AUC) | 95% CI | p-Value |
|---|---|---|---|---|---|---|
| Stages 3–4 | Myeloid dendritic cells BDCA1+CD19-TLR2+ | 22.22 | 0.91 | 0.96 | 0.89–1.0 | <0.0001 |
| B lymphocytes CD19+TLR-2+ | 5.62 | 0.49 | 0.78 | 0.64–0.95 | 0.0001 | |
| Adhesion | Myeloid dendritic cells BDCA1+CD19-TLR2+ | 20.45 | 0.81 | 0.92 | 0.83–1.0 | <0.0001 |
| B lymphocytes CD19+TLR-2+ | 6.16 | 0.59 | 0.82 | 0.70–0.95 | <0.0001 | |
| Non classical monocytes CD14+CD16+TLR2+ | 10.0 | 0.39 | 0.70 | 0.53–0.87 | 0.018 | |
| Infertility | Myeloid dendritic cells BDCA1+CD19-TLR2+ | 30.51 | 0.60 | 0.83 | 0.68–0.98 | <0.0001 |
| Plasmacytoid dendritic cells BDCA2+CD123+ TLR2+ | 12.5 | 0.55 | 0.71 | 0.55–0.88 | 0.009 | |
| B lymphocytes CD19+TLR-2+ | 2.95 | 0.41 | 0.73 | 0.57–0.89 | 0.006 |